Melanoma of unknown primary shows an oncogenic pattern and clinical course of sun-exposed melanoma
Georg Lodde(Essen University Hospital), Elisabeth Livingstone(German Cancer Research Center), Rudolf Herbst(Helios Klinikum Erfurt), Ralf Gutzmer(University Hospitals of the Ruhr-University of Bochum), Michael Weichenthal(Christian-Albrechts-Universität zu Kiel), Alexander Roesch(Essen University Hospital), Wolfgang Galetzka(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Florian Rambow(Essen University Hospital), Alpaslan Tasdogan(Düsseldorf University Hospital), Antje Sucker(German Cancer Research Center), Anne Zaremba(National Center for Tumor Diseases), Ulrike Leiter(University of Tübingen), Daniel J. Tilkorn(Essen University Hospital), J. Dollani(Essen University Hospital), Lisa Zimmer(Essen University Hospital), Andreas Stang(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Klaus Griewank(Essen University Hospital), Bastian Schilling(Goethe University Frankfurt), Friedegund Meier(National Cancer Centre Japan), Peter Mohr(Elbe Kliniken Stade-Buxtehude), Dirk Schadendorf(Essen University Hospital), Carola Berking(Comprehensive Cancer Center Erlangen), Jochen Utikal(German Cancer Research Center), S. Ugurel(Essen University Hospital), Claudia Pföhler(Saarland University), Patrick Terheyden(University Hospital Schleswig-Holstein)
Cited by 3
Related Papers
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
|Nature Genetics|2009|1.4k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k